Halt MS
The OSU Multiple Sclerosis Center is offering a clinical trial for MS patients with two or more relapses within the last twelve months while on disease modifying therapy. The study involves the use of bone marrow transplant as a treatment to arrest disease activity in patients with poor-risk RRMS.
Duration: Phase II, 5 year trial
Sponsor: NIH
Aim: to assess the use of bone marrow transplant as a treatment to arrest disease activity in patients with poor-risk RRMS.
Trial Website
http://www.halt-ms.org/
For more information or to enroll in this study, please contact Lisa Hafer in the Department of Neurology at 614-293-7877, or e-mail Lisa.Hafer@osumc.edu